Gilead Sciences Inc. (NASDAQ: GILD) reported late Tuesday that its second-quarter profit climbed to $746.2 million, or 93 cents a share, from $712.1 million, or 79 cents a share, in the year-earlier quarter. On an adjusted basis, the company earned $1 a share in the latest quarter. Revenue rose to $2.04 billion from $1.93 billion in the same quarter last year. Analysts, on average, had expected the company to report earnings of 99 cents a share on revenue of $2.08 billion.
Full Disclosure: None.
Full Disclosure: None.
